Please use this identifier to cite or link to this item:
|Title:||Clinical expression in 7 patients with malt lymphoma of the conjunctiva|
|Authors:||Oliveira, José Salvador Rodrigues de [UNIFESP]|
Colleoni,Gisele Wally Braga [UNIFESP]
Borducchi, Davimar Miranda Maciel [UNIFESP]
Rigueiro, Moacyr Pezati [UNIFESP]
Cha, S. B.
Gonzaga, Renato Luiz [UNIFESP]
Segretto, Roberto Araujo [UNIFESP]
Kerbauy, José [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
|Publisher:||Harwood Acad Publ Gmbh|
|Citation:||Cancer Research Therapy & Control. Reading: Harwood Acad Publ Gmbh, v. 5, n. 4, p. 319-322, 1998.|
|Abstract:||Problem: Lymphomas of conjunctiva are more common than is believed and immunohistologic analysis is able to distinguish benign and malignant lymphoid infiltrates. Methods: We analyzed seven cases of primary lymphoma of conjunctiva treated between November/1989 and April/1994. There were six females and one male with median age of 50 years (range 33-76 years). Results: Six patients were stage IE and one was IIE. At diagnosis, all but one had unilateral compromise of conjunctiva. All patients were classified as MALT lymphoma and six of them were positive for lambda light chain. Four patients were treated with combination of chemotherapy and bilateral radiotherapy and two received radiotherapy alone. One patient had bilateral relapse 12 months after chemotherapy alone and was successfully treated with radiotherapy. All cases treated with combined therapy achieved complete remission. Conclusion: Based on this experience, we suggest that combined treatment with chemotherapy and bilateral radiotherapy can prevent local relapse.|
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.